Anrukinzumab Antibody
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Its anti-inflammatory efficacy, validated in primate disease models, supports ongoing research for ulcerative colitis and asthma, including both in vivo and in vitro experimental applications.
Product Specifications
Product Name Alternative
IMA-638
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.15 mg/mL
Purity
97.00% (May vary between batches)
Molecular Weight
145.38 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6663508 1.0 µg DNA
Mcm5 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
MBS1154748-01 0.05 mg (E-Coli)
Recombinant Conus ventricosus Alpha-conotoxin-like Vn
Sign In for Pricing
View Details MBS1154748-02 0.2 mg (E-Coli)
Recombinant Conus ventricosus Alpha-conotoxin-like Vn
Sign In for Pricing
View Details MBS1154748-03 0.5 mg (E-Coli)
Recombinant Conus ventricosus Alpha-conotoxin-like Vn
Sign In for Pricing
View Details MBS1154748-04 0.05 mg (Yeast)
Recombinant Conus ventricosus Alpha-conotoxin-like Vn
Sign In for Pricing
View Details MBS1154748-05 0.05 mg (Baculovirus)
Recombinant Conus ventricosus Alpha-conotoxin-like Vn
Sign In for Pricing
View Details